American Cannabis Company, Inc. Provides Company Update On Overall Progress & Recent Activities
ACC has been vetting various partnership and strategic alliance opportunities.
Read More
Category: Featured News
Cara Therapeutics Reports First Quarter 2019 Financial Results
The Company reported a net loss of $22.0 million, or $0.56 per basic and diluted share, for the first quarter of 2019.
Read More
GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex
In this trial, EPIDIOLEX met its primary endpoint, which was the reduction in seizure frequency compared to baseline of the Epidiolex 25 mg/kg/day dose group vs placebo (p=0.0009).
Read More
Wildflower Brands Inc. Featured in Exclusive NetworkNewsWire Broadcast
The discussion about the company’s growth and global ambition to provide premium hemp-derived and CBD-based products to consumers who are looking for a different approach to health care.
Read More
What are Terpenes?
It’s believed that terpenes contribute towards cannabis’ overall therapeutic effect by working together with cannabinoids.
Read MoreGET LISTED
